BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharmaconomics//FDA Catalyst Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
BEGIN:VEVENT
UID:pharmaconomics-660@pharmaconomics
DTSTAMP:20260707T034206Z
DTSTART;VALUE=DATE:20291231
DTEND;VALUE=DATE:20300101
SUMMARY:CNTA Approval — cleminorexton (formerly ORX750) or ORX142 (estimated date)
DESCRIPTION:A final FDA approval decision on cleminorexton (formerly ORX750) or ORX142 for narcolepsy type 2 is expected ~ Dec 31\, 2029.\n\nPrimary source: https://www.sec.gov/Archives/edgar/data/1847903/000119312526134656/d145970dex991.htm\n\nTrack it: https://www.pharmaconomics.com/e/660
URL:https://www.pharmaconomics.com/e/660
TRANSP:TRANSPARENT
BEGIN:VALARM
TRIGGER:-P1D
ACTION:DISPLAY
DESCRIPTION:CNTA catalyst tomorrow
END:VALARM
END:VEVENT
END:VCALENDAR